- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05942924
The NEU-STIM Trial (NEU-STIM)
A Randomised Trial of Repetitive Versus Selective Tactile Stimulation for Preterm Infants at Birth: The NEU-STIM Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Rationale: A randomised study demonstrated that preterm infants who received repetitive stimulation at birth (10 second episodes of stroking of the soles of the feet and/or back, followed by 10 seconds rest) showed an increase in respiratory effort. This may in turn improve clinical outcomes as improved breathing effort may reduce the need for invasive respiratory support. Tactile stimulation can be immediately and easily performed at birth at no extra cost. It therefore has great potential to be implemented in delivery rooms (DRs) worldwide.
Objective: To determine the effect of repetitive tactile stimulation compared to selective stimulation on oxygenation of the infant at 5 minutes after birth.
Study design: This is a stepped-wedge cluster randomised controlled trial. The participating centre, rather than the individual infant, will be the unit of randomisation. This design is appropriate to test the effect of an intervention that encompasses a behavioral aspect - in this case the performance of tactile stimulation.
Study population: Infants born before 32 weeks of gestation will be included in this trial.
Intervention: At the start of the study, each participating centre will perform selective tactile stimulation in accordance with international guidelines, as is their usual practice. Clinicians will gently rub the back, chest, extremities or soles of the feet if they consider the breathing of the infant to be insufficient or absent. In the second stage of the study, centres will be randomised to switch their stimulation approach to repetitive stimulation. Clinicians will then gently rub the back, chest, extremities or soles of the feet for 10 seconds. To avoid extinction of the stimulatory effect (reflex), every 10 second period of stimulation will be followed by 10 seconds of rest (no stimulation). Repetitive stimulation will be performed for the first 5 minutes of life, or longer if the breathing is still considered insufficient or absent.
Main study parameter: The proportion of infants with pre-ductal oxygen saturation (SpO2) ≥ 80%.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Janneke Dekker, PhD
- Phone Number: +31715266620
- Email: j.dekker@lumc.nl
Study Contact Backup
- Name: Colm O'Donnell, MD PhD
- Phone Number: +35316373100
- Email: codonnell@nmh.ie
Study Locations
-
-
-
Graz, Austria, 8036
- Medical University of Graz
-
Contact:
- Nariae Baik-Schneditz, MD PhD
- Phone Number: +433163850
-
Principal Investigator:
- Nariae Baik-Schneditz, MD PhD
-
-
-
-
-
Rijeka, Croatia, 51000
- Clinical Hospital Center Rijeka
-
Contact:
- Iva Bilic Cace, MD PhD
- Phone Number: +38551658111
-
Principal Investigator:
- Iva Bilic Cace, MD PhD
-
-
-
-
-
Dublin, Ireland, D02 YH21
- National Maternity Hospital
-
Contact:
- Colm O'Donnell, MD PhD
- Phone Number: +35316373100
- Email: codonnell@nmh.ie
-
Principal Investigator:
- Colm O'Donnell, MD PhD
-
-
-
-
Zuid-Holland
-
Leiden, Zuid-Holland, Netherlands, 2333ZA
- Leiden University Medical Center
-
Contact:
- Janneke Dekker, PhD
- Phone Number: +31715266620
- Email: j.dekker@lumc.nl
-
Principal Investigator:
- Janneke Dekker, PhD
-
-
-
-
-
Valencia, Spain, 46026
- La Fe University Hospital
-
Contact:
- Celia Barber Almenar
- Phone Number: +34961244000
-
Principal Investigator:
- Celia Barber Almenar
-
Principal Investigator:
- Maximo Vento, MD PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Infants born before 32 weeks of gestation can be included in this trial after parental consent.
Exclusion Criteria:
- Infants will be excluded if they are found to have a congenital abnormality or condition that has an adverse effect on breathing/ventilation or oxygenation, including: congenital diaphragmatic hernia, trachea-oesophageal fistula, cyanotic heart disease and surfactant protein deficiency. Many of the infants enrolled in the study will later be diagnosed with respiratory distress syndrome (RDS); this will not render them ineligible for inclusion.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Selective stimulation
At the start of the study, selective tactile stimulation will be performed at each participating centre in accordance with international guidelines.
Clinicians will gently rub the back, chest, extremities or soles of the feet if they consider the breathing of the infant to be insufficient or absent.
All other procedures in the delivery room and NICU will be performed according to international and local guidelines.
|
See arm
|
Experimental: Repeated stimulation
For each centre, a lot will be drawn which indicates the month in which the protocol for tactile stimulation changes from selective stimulation to repetitive stimulation. Repetitive stimulation is defined as gently rubbing the soles of the feet, back, chest, or extremities for 10 seconds. To prevent extinction of the stimulatory effect (reflex), every 10 second period of stimulation will be followed by 10 seconds rest (no stimulation). The repetitive stimulation will be performed for the first 5 minutes after birth, or longer if the breathing is still considered insufficient or absent. All other procedures in the delivery room and NICU will be performed according to international and local guidelines. |
See arm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SpO2>80
Time Frame: At 5 minutes of life
|
Proportion of infants with pre-ductal SpO2 >80%
|
At 5 minutes of life
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heart rate
Time Frame: At 5 minutes after birth
|
Heart rate
|
At 5 minutes after birth
|
Number of infants who received CPAP <10min
Time Frame: Within 10 minutes after birth
|
Number of infants who received continuous positive airway pressure
|
Within 10 minutes after birth
|
Number of infants who received PPV <10min
Time Frame: Within 10 minutes after birth
|
Number of infants who received positive pressure ventilation
|
Within 10 minutes after birth
|
Number of infants who were intubated <10min
Time Frame: Within 10 minutes after birth
|
Number of infants who were endotracheally intubated
|
Within 10 minutes after birth
|
Number of infants who received chest compressions <10min
Time Frame: Within 10 minutes after birth
|
Within 10 minutes after birth
|
|
Number of infants who were administered adrenaline <10min
Time Frame: Within 10 minutes after birth
|
Adrenaline use
|
Within 10 minutes after birth
|
Number of infants who were administered volume expansion <10min
Time Frame: Within 10 minutes after birth
|
Within 10 minutes after birth
|
|
Max FiO2
Time Frame: In the first 10 minutes after birth
|
Maximum FiO2
|
In the first 10 minutes after birth
|
Death <10min
Time Frame: Within 10 minutes after birth
|
Within 10 minutes after birth
|
|
Number of infants who were supported by CPAP in first week
Time Frame: In the first week after birth
|
CPAP use in the NICU
|
In the first week after birth
|
Number of infants who received surfactant in first week
Time Frame: In the first week after birth
|
Surfactant administration via INSURE, LISA or ET tube
|
In the first week after birth
|
Surfactant doses
Time Frame: In the first week after birth
|
Number of surfactant doses administered
|
In the first week after birth
|
Number of infants who were mechanically ventilated >12h
Time Frame: In the first week after birth
|
Mechanical ventilation for more than 12hours
|
In the first week after birth
|
Number of infants with abnormalities on the first cranial ultrasound
Time Frame: In first week after birth
|
Abnormalities on first cranial ultrasound (IVH/PVL)
|
In first week after birth
|
Death
Time Frame: In the first week after birth
|
Mortality
|
In the first week after birth
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- N22.121
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infant, Premature, Diseases
-
University of MiamiPontificia Universidad Catolica de ChileTerminated
-
Aydin Adnan Menderes UniversityCompletedNursing Caries | Infant Development | Premature Infant Disease | Patient ComfortTurkey
-
University of VirginiaRecruitingDevelopment, Infant | Premature Infant DiseaseUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedInfant, Premature | Infant, Newborn
-
Istituto Giannina GasliniEubrainRecruiting
-
NICHD Neonatal Research NetworkNational Center for Research Resources (NCRR)CompletedSepsis | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, NewbornUnited States
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPreterm Birth | Cerebral Autoregulation | Premature Infant DiseaseItaly
-
Sun Yat-sen UniversityRecruitingPremature Infant DiseaseChina
-
Instituto Nacional de Perinatologia Isidro Espinosa...UnknownImmune System Diseases | Premature Infant Disease | Immunoglobulin DeficiencyMexico
-
Universidad de LeónCompletedPremature Birth | Premature Infant | Massage | Preterm Infant
Clinical Trials on Selective tactile stimulation
-
Virginia Polytechnic Institute and State UniversityRecruiting
-
Peter Tass, MD, PhDTerminatedParkinson DiseaseUnited States
-
University Hospital, GrenobleFaculty of Psychology and Educational Sciences,University of GenevaNot yet recruitingDevelopment, Child | Premature | Rooting ReflexFrance
-
Centre Psychothérapique de NancyRecruiting
-
University of TorontoUnknownPain Management | Healthy Infants | ImmunizationCanada
-
University Hospital, MontpellierRecruitingMajor Depressive Episode | Suicidal and Self-injurious BehaviorFrance
-
University of Mississippi, OxfordAuburn University; West Virginia University; University of Louisiana at LafayetteWithdrawn
-
King Saud UniversityCompletedHamstring Flexibility
-
University of MinnesotaRecruitingSpasmodic Dysphonia | Laryngeal DystoniaUnited States